OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trial
Joakim Øverbø, Asma Binte Aziz, Khalequ Zaman, et al.
Vaccine (2023) Vol. 41, Iss. 5, pp. 1059-1066
Open Access | Times Cited: 18
Joakim Øverbø, Asma Binte Aziz, Khalequ Zaman, et al.
Vaccine (2023) Vol. 41, Iss. 5, pp. 1059-1066
Open Access | Times Cited: 18
Showing 18 citing articles:
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
Shoujie Huang, Xuefeng Zhang, Yingying Su, et al.
The Lancet (2024) Vol. 403, Iss. 10429, pp. 813-823
Closed Access | Times Cited: 32
Shoujie Huang, Xuefeng Zhang, Yingying Su, et al.
The Lancet (2024) Vol. 403, Iss. 10429, pp. 813-823
Closed Access | Times Cited: 32
Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial
Khalequ Zaman, Cathinka Halle, Asma Binte Aziz, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 8, pp. e1288-e1299
Open Access | Times Cited: 9
Khalequ Zaman, Cathinka Halle, Asma Binte Aziz, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 8, pp. e1288-e1299
Open Access | Times Cited: 9
The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case–control and bias indicator study
Robin Nesbitt, Vincent Kinya Asilaza, Catia Alvarez, et al.
The Lancet Infectious Diseases (2025)
Open Access | Times Cited: 1
Robin Nesbitt, Vincent Kinya Asilaza, Catia Alvarez, et al.
The Lancet Infectious Diseases (2025)
Open Access | Times Cited: 1
A systematic review and meta-analysis assessing the safety and efficacy of the hepatitis E virus vaccine
Islam Mohamed, Hazem Abosheiashaa, Anna I. Boda, et al.
Baylor University Medical Center Proceedings (2025), pp. 1-7
Closed Access | Times Cited: 1
Islam Mohamed, Hazem Abosheiashaa, Anna I. Boda, et al.
Baylor University Medical Center Proceedings (2025), pp. 1-7
Closed Access | Times Cited: 1
Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection
Tatsuo Kanda, Tian‐Cheng Li, Masaharu Takahashi, et al.
Hepatology Research (2024) Vol. 54, Iss. 8, pp. 1-30
Open Access | Times Cited: 4
Tatsuo Kanda, Tian‐Cheng Li, Masaharu Takahashi, et al.
Hepatology Research (2024) Vol. 54, Iss. 8, pp. 1-30
Open Access | Times Cited: 4
Progress and Challenges to Hepatitis E Vaccine Development and Deployment
Xingcheng Huang, Jiaoxi Lu, Mengjun Liao, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 719-719
Open Access | Times Cited: 4
Xingcheng Huang, Jiaoxi Lu, Mengjun Liao, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 719-719
Open Access | Times Cited: 4
Immune memory in hepatitis E virus: a comparative study of natural infection and vaccination in a nursing home population
Xiaoyue Wu, Daixi Jiang, Yuxia Du, et al.
The Journal of Immunology (2025)
Closed Access
Xiaoyue Wu, Daixi Jiang, Yuxia Du, et al.
The Journal of Immunology (2025)
Closed Access
Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines
Ariel Bardach, Martín Brizuela, Mabel Berrueta, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Ariel Bardach, Martín Brizuela, Mabel Berrueta, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Cost‐Effectiveness Analysis of Hepatitis E Vaccination Strategies for Swine Workers
Fengge Wang, Zhou Lü, Yihan Lu
Transboundary and Emerging Diseases (2025) Vol. 2025, Iss. 1
Open Access
Fengge Wang, Zhou Lü, Yihan Lu
Transboundary and Emerging Diseases (2025) Vol. 2025, Iss. 1
Open Access
Hepatitis E Vaccines Updates
Christopher Hartley, Paul Wasuwanich, Trung Van, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 722-722
Open Access | Times Cited: 1
Christopher Hartley, Paul Wasuwanich, Trung Van, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 722-722
Open Access | Times Cited: 1
Raising the case of hepatitis E: Report from the 2nd international HEV symposium
Sophie Kang, Eun Hee Chung, Chloe Sye Lim Hong, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126398-126398
Closed Access | Times Cited: 1
Sophie Kang, Eun Hee Chung, Chloe Sye Lim Hong, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126398-126398
Closed Access | Times Cited: 1
Global vaccination against hepatitis E virus: position paper from the ESGVH-ESCMID
Susanne Dudman, Arjana Zerja, İmran Hasanoğlu, et al.
Clinical Microbiology and Infection (2024)
Open Access | Times Cited: 1
Susanne Dudman, Arjana Zerja, İmran Hasanoğlu, et al.
Clinical Microbiology and Infection (2024)
Open Access | Times Cited: 1
Hepatitis E Virus Infection Caused Elevation of Alanine Aminotransferase Levels in a Patient with Chronic Hepatitis B and Choledocholithiasis
Rei Hirano, Tatsuo Kanda, Masayuki Honda, et al.
Reports — Medical Cases Images and Videos (2023) Vol. 6, Iss. 4, pp. 55-55
Open Access | Times Cited: 3
Rei Hirano, Tatsuo Kanda, Masayuki Honda, et al.
Reports — Medical Cases Images and Videos (2023) Vol. 6, Iss. 4, pp. 55-55
Open Access | Times Cited: 3
Editorial: Pathogen-host interaction in the development of viral hepatitis
Shuxiang Li, Jiarui Li, Yunyang Xu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 1
Shuxiang Li, Jiarui Li, Yunyang Xu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 1
A pan-genotypic hepatitis E virus replication inhibitor with high potency in a rat infection model
Xin Zhang, Mara Klöhn, Sivi Ouwerkerk‐Mahadevan, et al.
Gastroenterology (2024)
Open Access
Xin Zhang, Mara Klöhn, Sivi Ouwerkerk‐Mahadevan, et al.
Gastroenterology (2024)
Open Access
Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatus
Kongxin Zhu, Mengjun Liao, Lu Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Kongxin Zhu, Mengjun Liao, Lu Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
An experimental chimeric hepatitis E virus vaccine elicits both local and systemic immune responses
Melisa Florencia Müller, Jacinto Sacur, Julia Matias Brancher, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Melisa Florencia Müller, Jacinto Sacur, Julia Matias Brancher, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Immunogenicity, Efficacy, and Effectiveness of Two-Dose and Shorter Schedules of Hepatitis E Vaccine: A Systematic Review
Mohammed Bilal Azam, Melanie Marti, Amit Goel, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 28-28
Open Access
Mohammed Bilal Azam, Melanie Marti, Amit Goel, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 28-28
Open Access
